advertisement

Topcon

Shen LQ 13

Showing records 1 to 13 | Display all abstracts from Shen LQ

86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Yousefi S
Ophthalmology 2020; 127: 1170-1178
86806 Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Cousins CC; Pan BX
American Journal of Ophthalmology 2020; 217: 10-19
86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Elze T
Ophthalmology 2020; 127: 1170-1178
86806 Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Chou JC
American Journal of Ophthalmology 2020; 217: 10-19
86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Pasquale LR; Saeedi O
Ophthalmology 2020; 127: 1170-1178
86806 Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Shen LQ
American Journal of Ophthalmology 2020; 217: 10-19
86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Wang M
Ophthalmology 2020; 127: 1170-1178
86806 Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Gordon MO
American Journal of Ophthalmology 2020; 217: 10-19
86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Shen LQ
Ophthalmology 2020; 127: 1170-1178
86806 Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Kass MA
American Journal of Ophthalmology 2020; 217: 10-19
86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Wellik SR
Ophthalmology 2020; 127: 1170-1178
86806 Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Ritch R; Pasquale LR
American Journal of Ophthalmology 2020; 217: 10-19
86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
De Moraes CG; Myers JS; Boland MV
Ophthalmology 2020; 127: 1170-1178

Issue 21-2

Change Issue


advertisement

Oculus